πŸ‡ΊπŸ‡Έ FDA
Patent

US 11357783

Conjugate of finasteride with peptide

granted A61KA61K2800/57A61K31/56

Quick answer

US patent 11357783 (Conjugate of finasteride with peptide) held by CAREGEN CO., LTD. expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2800/57, A61K31/56, A61K31/58, A61K47/64